This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Camici, P. G. Articles by Rimoldi, O. E. Search for Related Content PubMed PubMed Citation Articles by Camici, P. G. Articles by Rimoldi, O. E. Related Collections Imaging Related Article

Editorial

A Novel ¹⁸F-Labeled Tracer for the Quantification of Myocardial Blood Flow and Infarct Size With Positron-Emission Tomography

Another Way to Avoid the Need of an On-Site Cyclotron

Paolo G. Camici, MD and Ornella E. Rimoldi, MD

From the Medical Research Council Clinical Sciences Centre (P.G.C., O.E.R.) and the National Heart and Lung Institute (P.G.C., O.E.R.), Imperial College, London, United Kingdom; and Consiglio Nazionale delle Ricerche (O.E.R.), Institute of Clinical Physiology, Pisa, Italy.

Correspondence to Paolo G. Camici, MD, MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. E-mail paolo.camici@csc.mrc.ac.uk

Key Words: Editorials • imaging

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Currently, nuclear imaging techniques can be used to diagnose coronary macrovascular and microvascular disease and to measure infarct size and left ventricular ejection fraction. Semiquantitative assessment of regional myocardial perfusion with single-photon emission computed tomography is a noninvasive, robust, and widely available method of assessing myocardial ischemia and has an established role in the clinical setting.¹ A great number of studies have assessed the sensitivity and specificity of this technique for the detection of coronary artery disease (CAD), with coronary arteriography usually being used as the standard by which the accuracy of scintigraphy is judged.¹ The main limitation of single-photon emission computed tomography perfusion imaging is that it provides only semiquantitative information on the regional distribution of myocardial blood flow (MBF). This is particularly relevant in conditions in which MBF and coronary flow reserve (CFR) are diffusely abnormal, (eg, in patients with hypertrophic and dilated cardiomyopathies).²

Article p 77

The ability to make quantitative measurements of MBF with positron-emission tomography (PET) allows determination of the functional significance of epicardial coronary lesions. In patients with single-vessel CAD, chronic stable angina, and no previous history of myocardial infarction (MI), CFR in response to a standard dose of dipyridamole was found to be markedly reduced in the myocardial regions subtended by the stenosed coronary artery compared with regions subtended by angiographically normal vessels.³ Using H₂¹⁵O or ¹³NH₃ with PET, the relationship between stenosis severity, measured by quantitative coronary angiography, and its consequences on regional MBF and CFR has been described.^4,5 Furthermore, the . . . [Full Text of this Article]

Related Article

Evaluation of a Novel ¹⁸F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats

Hossam M. Sherif, Antti Saraste, Eliane Weidl, Axel W. Weber, Takahiro Higuchi, Sybille Reder, Thorsten Poethko, Gjermund Henriksen, David Casebier, Simon Robinson, Hans-Jürgen Wester, Stephan G. Nekolla, and Markus Schwaiger
Circ Cardiovasc Imaging 2009 2: 77-84. [Abstract] [Full Text] [PDF]